Target intelligence / Profile preview

Host vascular and retinal microenvironment engaged by hiPSC-derived vascular reparative cells

Molecular classification
Receptor, Chemokine, Cell therapy, Signal transduction pathway
01

Overview

The host vascular and retinal microenvironment engaged by hiPSC-derived vascular reparative cells refers to the complex interaction between therapeutic human induced pluripotent stem cell (hiPSC)-derived cells and the damaged retinal tissue in conditions such as diabetic retinopathy (DR). This engagement is primarily mediated by the SDF-1/CXCR4 signaling axis, where stromal cell-derived factor-1 (SDF-1/CXCL12) is upregulated in the ischemic or diabetic retina, acting as a chemoattractant for CXCR4-expressing vascular reparative cells, including CD34+ progenitors and endothelial colony-forming cells (ECFCs) (Gil et al., 2024, Cells). Upon homing to the site of injury, these cells integrate into the host's retinal vasculature and provide essential trophic support through the secretion of growth factors and anti-inflammatory cytokines, which helps restore vascular integrity and reduce capillary leakage (Park et al., 2020, JCI Insight). Recent studies using Reverse Phase Protein Array (RPPA) analysis have shown that this engagement triggers significant host responses in pathways such as PI3K-AKT-mTOR, glycolysis, and endothelial junction regulation, which are critical for maintaining retinal structure and function (Gil et al., 2025, Cells). Additionally, pharmacological agents like DMHCA have been shown to enhance the mobilization and function of these reparative cells by modulating the bone marrow and retinal microenvironments (Grant et al., 2022, Science Advances). This multi-faceted therapeutic strategy aims to reverse vasodegeneration and neuroretinal dysfunction in ischemic retinopathies.

Other names
SDF-1/CXCR4 axis in retinal repairhiPSC-derived CD34+ cell therapyhiPSC-derived endothelial colony-forming cell (ECFC) therapyVascular reparative cell (VRC) engagementDiabetic retinal microenvironment targeting
02

Mechanism of action

The therapeutic approach involves the homing of hiPSC-derived vascular reparative cells to the ischemic retinal microenvironment via the SDF-1/CXCR4 chemotactic gradient, followed by their integration into the host vasculature and the secretion of paracrine factors that promote vascular stabilization and neuroprotection.

03

Biological functions

Cell homingVascular repairAngiogenesisParacrine signalingTissue regenerationEndothelial stabilization
04

Disease associations

Diabetic retinopathyIschemic retinopathyRetinal vascular degenerationAge-related macular degeneration
05

Safety considerations

Potential for off-target cell integrationRisk of exacerbating pathological neovascularizationImmune rejection of allogeneic cellsLong-term stability of integrated cells in the host microenvironment
06

Interacting drugs

hiPSC-derived CD34+ cells

3 more in the full profile.

07

Biomarkers

CD34CXCR4 (C-X-C chemokine receptor type 4)SDF-1 (CXCL12)VEGFR2 (CD309/KDR)HNA (Human Nuclear Antigen)

Beyond the preview

Go deeper on Host vascular and retinal microenvironment engaged by hiPSC-derived vascular reparative cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host vascular and retinal microenvironment engaged by hiPSC-derived vascular reparative cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call